← Open Payments lookup

KEVIN MOYNIHAN: Open Payments

NPI 1982709028 · LODI, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$924 in 46 payments from 17 companies in 2025. Trend: 2023 $863 · 2024 $950 · 2025 $924

Food & beverage: $924
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$225
Novo Nordisk Inc6$119
Regeneron Healthcare Solutions, Inc.3$81
Lilly USA, LLC3$74
Exact Sciences Corporation3$55
Phathom Pharmaceuticals, Inc.4$54
Boehringer Ingelheim Pharmaceuticals, Inc.3$51
GlaxoSmithKline, LLC.2$51
Organogenesis Inc.2$41
Novartis Pharmaceuticals Corporation1$28

Products named: AIRSUPRA, DUPIXENT, MOUNJARO, FARXIGA, Ozempic, VOQUEZNA, BREZTRI, JARDIANCE.

Industry payments across CA — which companies pay providers there.